Bioclinica's unified IRT and Trial Supply Optimization (TSO) solution, which holistically integrates real IRT study data with the ability to model and forecast future study behavior.
Translation skills
Main profile
Ehsan Ramezani
Senior Director, Clinical Solutions
Ehsan is a subject matter expert in randomization and trial supply management solutions responsible for supporting all customer-facing teams at Bioclinica. He has 20+ years’ experience in the clinical supply technology solutions domain in a variety of operational, commercial and product development roles within sponsors, CROs and software organizations.
Blogs
One of our strategic customers recently invited me to review a draft protocol synopsis for a pivotal Phase III registration study. As the provider of the randomization and trial supply management (RTSM) solution for the study, I relished the opportunity.
LEARN MORE OR SPEAK WITH OUR EXPERTS
CONTACT USLeader in Clinical Trial
Management Solutions
Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.
Quick Links:
Language:
Bioclinica's #ClinicalDataManagement ecosystem of global experts, templates, coding tools and more fills the gap in… https://t.co/W5swfW70Ws
Not sure what questions to ask your clinical adjudication provider when transitioning a project to a new provider?… https://t.co/Tb2TXXuNa9
A clinical trial rescue or transition presents a unique set of challenges for study teams. Join us on July 21 for a… https://t.co/whD4O3w6QB
Save time and minimize risk with Bioclinica’s Clinical Trial Management System (CTMS) Starter Package. A fully feat… https://t.co/AgcXHWCg80
It takes a village to manage #clinicaltrial data. Watch our video to learn how to leverage our Clinical… https://t.co/F7yof0B6zH
The Clinical Trial Management System (CTMS) Starter Package from Bioclinica saves time and minimizes the risk often… https://t.co/EDhe0Qokla